石四药集团：取得药监局有关吲哚布芬片(0.2g)的药品生产注册批件

Core Viewpoint - The company has obtained the drug production registration approval from the National Medical Products Administration of China for Indobufene Tablets (0.2g), classified as a Class 3 chemical drug, which is considered equivalent to passing the consistency evaluation [1] Group 1 - Indobufene Tablets are primarily used for the treatment of ischemic cardiovascular diseases caused by arteriosclerosis, ischemic cerebrovascular diseases, and venous thrombosis [1] - The drug can also be used to prevent thrombosis during hemodialysis [1]